SCHEMBL1848745

SCHEMBL1848745

Cc1ccc(-c2ccoc2C(=O)NC2CCN(CCC3(CCN4C(=O)c5ccccc5C4=O)CCCCC3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HTR4 Q13639 3/20 0.41
MCHR1 Q99705 2/20 0.39
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.36
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CHRM2 P08172 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690432 0.88 MCHR1 (0.39) ALDH1A1MCHR1HPGDCARM1PRMT6
SCHEMBL4693190 0.87 L3MBTL1 (0.39) ALDH1A1MCHR1CARM1PRMT6L3MBTL1
SCHEMBL4687554 0.87 L3MBTL1 (0.38) ALDH1A1MCHR1HPGDMAPK1CARM1
SCHEMBL4691461 0.86 MCHR1 (0.38) ALDH1A1MCHR1L3MBTL1SMN1; SMN2LMNA
SCHEMBL4688285 0.86 L3MBTL1 (0.36) ALDH1A1HTR4MCHR1CARM1PRMT6
SCHEMBL5107097 0.85 L3MBTL1 (0.36) ALDH1A1MCHR1CARM1PRMT6L3MBTL1
SCHEMBL4689921 0.84 HTR7 (0.43) ALDH1A1MCHR1HPGDSMN1; SMN2LMNA
SCHEMBL4690036 0.84 MCHR1 (0.36) ALDH1A1MCHR1L3MBTL1SMN1; SMN2
SCHEMBL4688480 0.84 MCHR1 (0.33) ALDH1A1HTR4MCHR1CARM1PRMT6
SCHEMBL4690581 0.83 HTR7 (0.44) MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2325183-A1 4-(2-Furoyl) Aminopiperidine compound useful as therapeutic agent for itching Kyorin Pharmaceutical Co., Ltd. (JP) 2011-05-25 EP disclosed
US-7601843-B2 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching KYORIN PHARMACEUTICAL CO., LTD (JP) 2009-10-13 US disclosed
US-20060270632-A1 4-(2-Furoyl) aminopiperidine compound useful as therapeutic agent for itching KYORIN PHARMACEUTICAL CO., LTD NISSHIN SEIFUN GROUP INC. 2006-11-30 US disclosed
EP-1621538-A1 4-(2-FUROYL)AMINOPIPERIDINE COMPOUND USEFUL AS THERAPEUTIC AGENT FOR ITCHING Kyorin Pharmaceutical Co., Ltd. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270632-A1 4-(2-Furoyl) aminopiperidine compound useful as therapeutic agent for itching HRH4, HRH3, HRH2 ALDH1A1 2669/4885HTR4 34/4885MCHR1 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.